Coronary artery changes in patients with Kawasaki disease

Kawasaki disease (KD) is an acute, self‐limiting, systemic vasculitis of unknown aetiology, which most commonly occurs in children aged 6 mo to 5 y, with a peak incidence at 9–11 mo. The inflammatory process preferentially involves the coronary arteries, potentially resulting in coronary arteritis,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta Paediatrica 2004-11, Vol.93 (s446), p.75-79
Hauptverfasser: Tulloh, RMR, Wood, LE
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 79
container_issue s446
container_start_page 75
container_title Acta Paediatrica
container_volume 93
creator Tulloh, RMR
Wood, LE
description Kawasaki disease (KD) is an acute, self‐limiting, systemic vasculitis of unknown aetiology, which most commonly occurs in children aged 6 mo to 5 y, with a peak incidence at 9–11 mo. The inflammatory process preferentially involves the coronary arteries, potentially resulting in coronary arteritis, aneurysmal lesions, arterial thrombotic occlusion and sudden death. Kawasaki disease is the most common cause of acquired coronary vessel abnormalities in children. The cause of KD is not known, but evidence is presented for an inflammatory response and a genetic predisposition. The diagnostic tests are not yet defined, but treatment with immunoglobulin and aspirin is effective at reducing the risk of cardiac complications from 25% to 4.7% in the UK. Sequelae may occur, either acutely with myocardial, endocardial or pericardial inflammation, or many years after the original illness. There may be abnormalities of myocardial blood flow as assessed by MRI, radio‐nucleide studies or echo Doppler. Such abnormalities of coronary arteries may require ongoing medication, interventional catheterization or even cardiac surgery. Conclusion: In the future, we hope to have more accurate diagnostic tests or prophylaxis against the disease, in addition to improved means of determining the susceptibility to or presence of long‐term complications.
doi_str_mv 10.1111/j.1651-2227.2004.tb00243.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67244935</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67244935</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2845-a8edbb7587db510f54a49b6f003c2d60e12f4e4d0ce63139688aecf1bcb477773</originalsourceid><addsrcrecordid>eNqVkM1u1DAURi0EokPhFVCEBLsE_ztBYjGMaIsYCgsQS-vGuaGeZpKpndFM376OJmrX3M1d-Hy2v0PIO0YLlubjpmBasZxzbgpOqSzGmlIuRXF8RhaPR8_JgpZU5IorcUZexbhJkKikfknOmDKUayMXpFoNYegh3GcQRkzL3UD_D2Pm-2wHo8d-jNnBjzfZdzhAhFufNT4iRHxNXrTQRXwz73Py5-Lr79VVvv55-W21XOeOl1LlUGJT10aVpqkVo62SIKtat5QKxxtNkfFWomyoQy2YqHRZArqW1a6WJo04Jx9O9-7CcLfHONqtjw67Dnoc9tFqw6WshErgpxPowhBjwNbugt-mapZRO4mzGzvZsZMdO4mzszh7TOG38yv7eovNU3Q2lYD3MwDRQdcG6J2PT5wWVcWoSNznE3fwHd7_xxfs8tfSTC3yU97HEY-PeQi3qakwyv69vrTrH9XVNVXCfhEPqNuYpg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67244935</pqid></control><display><type>article</type><title>Coronary artery changes in patients with Kawasaki disease</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Alma/SFX Local Collection</source><creator>Tulloh, RMR ; Wood, LE</creator><creatorcontrib>Tulloh, RMR ; Wood, LE</creatorcontrib><description>Kawasaki disease (KD) is an acute, self‐limiting, systemic vasculitis of unknown aetiology, which most commonly occurs in children aged 6 mo to 5 y, with a peak incidence at 9–11 mo. The inflammatory process preferentially involves the coronary arteries, potentially resulting in coronary arteritis, aneurysmal lesions, arterial thrombotic occlusion and sudden death. Kawasaki disease is the most common cause of acquired coronary vessel abnormalities in children. The cause of KD is not known, but evidence is presented for an inflammatory response and a genetic predisposition. The diagnostic tests are not yet defined, but treatment with immunoglobulin and aspirin is effective at reducing the risk of cardiac complications from 25% to 4.7% in the UK. Sequelae may occur, either acutely with myocardial, endocardial or pericardial inflammation, or many years after the original illness. There may be abnormalities of myocardial blood flow as assessed by MRI, radio‐nucleide studies or echo Doppler. Such abnormalities of coronary arteries may require ongoing medication, interventional catheterization or even cardiac surgery. Conclusion: In the future, we hope to have more accurate diagnostic tests or prophylaxis against the disease, in addition to improved means of determining the susceptibility to or presence of long‐term complications.</description><identifier>ISSN: 0803-5253</identifier><identifier>ISSN: 0803-5326</identifier><identifier>EISSN: 1651-2227</identifier><identifier>DOI: 10.1111/j.1651-2227.2004.tb00243.x</identifier><identifier>PMID: 15702674</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Aspirin ; Biological and medical sciences ; Child ; Child, Preschool ; coronary aneurysms ; Coronary Circulation - physiology ; Coronary Disease - diagnosis ; Coronary Disease - etiology ; Coronary Disease - prevention &amp; control ; Coronary Vessels - pathology ; Coronary Vessels - physiopathology ; endothelial dysfunction ; Endothelium, Vascular - pathology ; Endothelium, Vascular - physiopathology ; Fundamental and applied biological sciences. Psychology ; Genetics of eukaryotes. Biological and molecular evolution ; Humans ; immunoglobulin ; Infant ; Medical genetics ; Medical sciences ; Molecular and cellular biology ; Mucocutaneous Lymph Node Syndrome - diagnosis ; Mucocutaneous Lymph Node Syndrome - pathology ; Mucocutaneous Lymph Node Syndrome - physiopathology ; Mucocutaneous Lymph Node Syndrome - therapy ; vasculitis</subject><ispartof>Acta Paediatrica, 2004-11, Vol.93 (s446), p.75-79</ispartof><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2845-a8edbb7587db510f54a49b6f003c2d60e12f4e4d0ce63139688aecf1bcb477773</citedby><cites>FETCH-LOGICAL-c2845-a8edbb7587db510f54a49b6f003c2d60e12f4e4d0ce63139688aecf1bcb477773</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1651-2227.2004.tb00243.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1651-2227.2004.tb00243.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>309,310,314,776,780,785,786,1411,23909,23910,25118,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16399103$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15702674$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tulloh, RMR</creatorcontrib><creatorcontrib>Wood, LE</creatorcontrib><title>Coronary artery changes in patients with Kawasaki disease</title><title>Acta Paediatrica</title><addtitle>Acta Paediatr Suppl</addtitle><description>Kawasaki disease (KD) is an acute, self‐limiting, systemic vasculitis of unknown aetiology, which most commonly occurs in children aged 6 mo to 5 y, with a peak incidence at 9–11 mo. The inflammatory process preferentially involves the coronary arteries, potentially resulting in coronary arteritis, aneurysmal lesions, arterial thrombotic occlusion and sudden death. Kawasaki disease is the most common cause of acquired coronary vessel abnormalities in children. The cause of KD is not known, but evidence is presented for an inflammatory response and a genetic predisposition. The diagnostic tests are not yet defined, but treatment with immunoglobulin and aspirin is effective at reducing the risk of cardiac complications from 25% to 4.7% in the UK. Sequelae may occur, either acutely with myocardial, endocardial or pericardial inflammation, or many years after the original illness. There may be abnormalities of myocardial blood flow as assessed by MRI, radio‐nucleide studies or echo Doppler. Such abnormalities of coronary arteries may require ongoing medication, interventional catheterization or even cardiac surgery. Conclusion: In the future, we hope to have more accurate diagnostic tests or prophylaxis against the disease, in addition to improved means of determining the susceptibility to or presence of long‐term complications.</description><subject>Aspirin</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>coronary aneurysms</subject><subject>Coronary Circulation - physiology</subject><subject>Coronary Disease - diagnosis</subject><subject>Coronary Disease - etiology</subject><subject>Coronary Disease - prevention &amp; control</subject><subject>Coronary Vessels - pathology</subject><subject>Coronary Vessels - physiopathology</subject><subject>endothelial dysfunction</subject><subject>Endothelium, Vascular - pathology</subject><subject>Endothelium, Vascular - physiopathology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Genetics of eukaryotes. Biological and molecular evolution</subject><subject>Humans</subject><subject>immunoglobulin</subject><subject>Infant</subject><subject>Medical genetics</subject><subject>Medical sciences</subject><subject>Molecular and cellular biology</subject><subject>Mucocutaneous Lymph Node Syndrome - diagnosis</subject><subject>Mucocutaneous Lymph Node Syndrome - pathology</subject><subject>Mucocutaneous Lymph Node Syndrome - physiopathology</subject><subject>Mucocutaneous Lymph Node Syndrome - therapy</subject><subject>vasculitis</subject><issn>0803-5253</issn><issn>0803-5326</issn><issn>1651-2227</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkM1u1DAURi0EokPhFVCEBLsE_ztBYjGMaIsYCgsQS-vGuaGeZpKpndFM376OJmrX3M1d-Hy2v0PIO0YLlubjpmBasZxzbgpOqSzGmlIuRXF8RhaPR8_JgpZU5IorcUZexbhJkKikfknOmDKUayMXpFoNYegh3GcQRkzL3UD_D2Pm-2wHo8d-jNnBjzfZdzhAhFufNT4iRHxNXrTQRXwz73Py5-Lr79VVvv55-W21XOeOl1LlUGJT10aVpqkVo62SIKtat5QKxxtNkfFWomyoQy2YqHRZArqW1a6WJo04Jx9O9-7CcLfHONqtjw67Dnoc9tFqw6WshErgpxPowhBjwNbugt-mapZRO4mzGzvZsZMdO4mzszh7TOG38yv7eovNU3Q2lYD3MwDRQdcG6J2PT5wWVcWoSNznE3fwHd7_xxfs8tfSTC3yU97HEY-PeQi3qakwyv69vrTrH9XVNVXCfhEPqNuYpg</recordid><startdate>200411</startdate><enddate>200411</enddate><creator>Tulloh, RMR</creator><creator>Wood, LE</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200411</creationdate><title>Coronary artery changes in patients with Kawasaki disease</title><author>Tulloh, RMR ; Wood, LE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2845-a8edbb7587db510f54a49b6f003c2d60e12f4e4d0ce63139688aecf1bcb477773</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Aspirin</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>coronary aneurysms</topic><topic>Coronary Circulation - physiology</topic><topic>Coronary Disease - diagnosis</topic><topic>Coronary Disease - etiology</topic><topic>Coronary Disease - prevention &amp; control</topic><topic>Coronary Vessels - pathology</topic><topic>Coronary Vessels - physiopathology</topic><topic>endothelial dysfunction</topic><topic>Endothelium, Vascular - pathology</topic><topic>Endothelium, Vascular - physiopathology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Genetics of eukaryotes. Biological and molecular evolution</topic><topic>Humans</topic><topic>immunoglobulin</topic><topic>Infant</topic><topic>Medical genetics</topic><topic>Medical sciences</topic><topic>Molecular and cellular biology</topic><topic>Mucocutaneous Lymph Node Syndrome - diagnosis</topic><topic>Mucocutaneous Lymph Node Syndrome - pathology</topic><topic>Mucocutaneous Lymph Node Syndrome - physiopathology</topic><topic>Mucocutaneous Lymph Node Syndrome - therapy</topic><topic>vasculitis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tulloh, RMR</creatorcontrib><creatorcontrib>Wood, LE</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Acta Paediatrica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tulloh, RMR</au><au>Wood, LE</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Coronary artery changes in patients with Kawasaki disease</atitle><jtitle>Acta Paediatrica</jtitle><addtitle>Acta Paediatr Suppl</addtitle><date>2004-11</date><risdate>2004</risdate><volume>93</volume><issue>s446</issue><spage>75</spage><epage>79</epage><pages>75-79</pages><issn>0803-5253</issn><issn>0803-5326</issn><eissn>1651-2227</eissn><abstract>Kawasaki disease (KD) is an acute, self‐limiting, systemic vasculitis of unknown aetiology, which most commonly occurs in children aged 6 mo to 5 y, with a peak incidence at 9–11 mo. The inflammatory process preferentially involves the coronary arteries, potentially resulting in coronary arteritis, aneurysmal lesions, arterial thrombotic occlusion and sudden death. Kawasaki disease is the most common cause of acquired coronary vessel abnormalities in children. The cause of KD is not known, but evidence is presented for an inflammatory response and a genetic predisposition. The diagnostic tests are not yet defined, but treatment with immunoglobulin and aspirin is effective at reducing the risk of cardiac complications from 25% to 4.7% in the UK. Sequelae may occur, either acutely with myocardial, endocardial or pericardial inflammation, or many years after the original illness. There may be abnormalities of myocardial blood flow as assessed by MRI, radio‐nucleide studies or echo Doppler. Such abnormalities of coronary arteries may require ongoing medication, interventional catheterization or even cardiac surgery. Conclusion: In the future, we hope to have more accurate diagnostic tests or prophylaxis against the disease, in addition to improved means of determining the susceptibility to or presence of long‐term complications.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>15702674</pmid><doi>10.1111/j.1651-2227.2004.tb00243.x</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0803-5253
ispartof Acta Paediatrica, 2004-11, Vol.93 (s446), p.75-79
issn 0803-5253
0803-5326
1651-2227
language eng
recordid cdi_proquest_miscellaneous_67244935
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Alma/SFX Local Collection
subjects Aspirin
Biological and medical sciences
Child
Child, Preschool
coronary aneurysms
Coronary Circulation - physiology
Coronary Disease - diagnosis
Coronary Disease - etiology
Coronary Disease - prevention & control
Coronary Vessels - pathology
Coronary Vessels - physiopathology
endothelial dysfunction
Endothelium, Vascular - pathology
Endothelium, Vascular - physiopathology
Fundamental and applied biological sciences. Psychology
Genetics of eukaryotes. Biological and molecular evolution
Humans
immunoglobulin
Infant
Medical genetics
Medical sciences
Molecular and cellular biology
Mucocutaneous Lymph Node Syndrome - diagnosis
Mucocutaneous Lymph Node Syndrome - pathology
Mucocutaneous Lymph Node Syndrome - physiopathology
Mucocutaneous Lymph Node Syndrome - therapy
vasculitis
title Coronary artery changes in patients with Kawasaki disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T23%3A30%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Coronary%20artery%20changes%20in%20patients%20with%20Kawasaki%20disease&rft.jtitle=Acta%20Paediatrica&rft.au=Tulloh,%20RMR&rft.date=2004-11&rft.volume=93&rft.issue=s446&rft.spage=75&rft.epage=79&rft.pages=75-79&rft.issn=0803-5253&rft.eissn=1651-2227&rft_id=info:doi/10.1111/j.1651-2227.2004.tb00243.x&rft_dat=%3Cproquest_cross%3E67244935%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67244935&rft_id=info:pmid/15702674&rfr_iscdi=true